Speaker
Associate Director, Medicinal Chemistry, AstraZeneca
Alyn Davies, Associate Director, Medicinal Chemistry at AstraZeneca, appears in the programmes of 2 conferences on kongre.net. Most recently: 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026).
26–29 Oct 2026Boston, United States of America
12–15 Oct 2026San Diego, United States of America
Professor, Harvard Medical School
President & Chief Executive Officer, Arvinas, Inc.
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Science Partner, Flagship Pioneering
Chief Business Officer, Nurix Therapeutics, Inc.
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Chief Scientific Officer, Iksuda Therapeutics
Senior Director, Chemistry, Sutro Biopharma
Chief Scientific Officer, Callio Therapeutics
President & Founder, Bramhill Biologics Consulting
Executive Director, Product Stewardship Lead, AstraZeneca
Senior Director - Bioconjugation Chemistry, Abzena
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Alyn Davies, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].